BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 14, Issue 22
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (3987)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.
Item 
Count 
PDF527
HTML3057
Figures (1-2)197
Tables (1-3)206
 Sum=3987
Jun 14, 2008 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Sokol H, Cosnes J, Chazouilleres O, Beaugerie L, Tiret E, Poupon R, Seksik P. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol 2008; 14(22): 3497-3503 [PMID: 18567077 DOI: 10.3748/wjg.14.3497]
URL: https://www.wjgnet.com/1007-9327/full/v14/i22/3497.htm
Number Citing Articles
1
Hitoshi Sano, Takahiro Nakazawa, Tomoaki Ando, Kazuki Hayashi, Itaru Naitoh, Fumihiro Okumura, Katsuyuki Miyabe, Michihiro Yoshida, Satoru Takahashi, Hirotaka Ohara, Takashi Joh. Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis. Journal of Hepato-Biliary-Pancreatic Sciences 2011; 18(2): 154 doi: 10.1007/s00534-010-0319-8
2
Cyriel Y. Ponsioen, David N. Assis, Kirsten M. Boberg, Christopher L. Bowlus, Mark Deneau, Douglas Thorburn, Lars Aabakken, Martti Färkkilä, Bret Petersen, Christian Rupp, Stefan G. Hübscher. Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Gastroenterology 2021; 161(6): 1764 doi: 10.1053/j.gastro.2021.07.046
3
J. Torres, G. Pineton de Chambrun, S. Itzkowitz, D. B. Sachar, J.-F. Colombel. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2011; 34(5): 497 doi: 10.1111/j.1365-2036.2011.04753.x
4
A Boudewijn de Vries, Marcel Janse, Hans Blokzijl, Rinse K Weersma. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World Journal of Gastroenterology 2015; 21(6): 1956-1971 doi: 10.3748/wjg.v21.i6.1956
5
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar. Approaches to the design of clinical trials for primary sclerosing cholangitis. Clinical Investigation 2012; 2(8): 769 doi: 10.4155/cli.12.75
6
Emmanouil Sinakos, Sunil Samuel, Felicity Enders, Edward V. Loftus, William J. Sandborn, Keith D. Lindor. Inflammatory Bowel Disease in Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 2013; 19(5): 1004 doi: 10.1097/MIB.0b013e3182802893
7
Ashwin N. Ananthakrishnan, Dawn B. Beaulieu, Alex Ulitsky, Yelena Zadvornova, Sue Skaros, Kathryn Johnson, Amar Naik, Lilani Perera, Mazen Issa, David G. Binion, Kia Saeian. Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease?. Inflammatory Bowel Diseases 2010; 16(3): 494 doi: 10.1002/ibd.21051
8
D. Debray. Hépatologie de L'enfant. 2018; : 179 doi: 10.1016/B978-2-294-75788-4.00026-3
9
Hwajeong Lee, Maria Westerhoff, Bo Shen, Xiuli Liu. Clinical Aspects of Idiopathic Inflammatory Bowel Disease: A Review for Pathologists. Archives of Pathology & Laboratory Medicine 2016; 140(5): 413 doi: 10.5858/arpa.2015-0305-RA
10
Monica Di Paola, Lisa Rizzetto, Irene Stefanini, Francesco Vitali, Cristina Massi-Benedetti, Noemi Tocci, Luigina Romani, Matteo Ramazzotti, Paolo Lionetti, Carlotta De Filippo, Duccio Cavalieri. Comparative immunophenotyping of Saccharomyces cerevisiae and Candida spp. strains from Crohn’s disease patients and their interactions with the gut microbiome. Journal of Translational Autoimmunity 2020; 3: 100036 doi: 10.1016/j.jtauto.2020.100036
11
Crystal Knight, Karen F Murray. Hepatobiliary associations with inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2009; 3(6): 681 doi: 10.1586/egh.09.53
12
Jennifer L Dotson, Jeffrey S Hyams, James Markowitz, Neal S LeLeiko, David R Mack, Jonathan S Evans, Marian D Pfefferkorn, Anne M Griffiths, Anthony R Otley, Athos Bousvaros, Subra Kugathasan, Joel R Rosh, David Keljo, Ryan S Carvalho, Gitit Tomer, Petar Mamula, Marsha H Kay, Benny Kerzner, Maria Oliva‐Hemker, Christine R Langton, Wallace Crandall. Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease and Their Relation to Disease Type and Severity. Journal of Pediatric Gastroenterology and Nutrition 2010; 51(2): 140 doi: 10.1097/MPG.0b013e3181ca4db4
13
Tina Boortalary, David Loren. Hepato-Pancreato-Biliary Malignancies. 2022; : 237 doi: 10.1007/978-3-030-41683-6_15
14
Ingrid Banovic, Daniel Gilibert, Ahmed Jebrane, Jacques Cosnes. Personality and fatigue perception in a sample of IBD outpatients in remission: A preliminary study. Journal of Crohn's and Colitis 2012; 6(5): 571 doi: 10.1016/j.crohns.2011.11.006
15
Mohamad A Mouchli, Siddharth Singh, Lisa Boardman, David H Bruining, Amy L Lightner, Charles B Rosen, Julie K Heimbach, Bashar Hasan, John J Poterucha, Kymberly D Watt, Sunanda V Kane, Laura E Raffals, Edward V Loftus. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 2018; 24(5): 1074 doi: 10.1093/ibd/izx096
16
Alireza Beheshti-Maal, Atena Tamimi, Shahrokh Iravani, Arash Memarnejadian, Majid Sorouri, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Nikoo Hossein Khannazer, Massoud Vosough. PSC associated inflammatory bowel disease: a distinct entity. Expert Review of Gastroenterology & Hepatology 2022; 16(2): 129 doi: 10.1080/17474124.2022.2031979
17
Lina Lindström, Annika Lapidus, Åke Öst, Annika Bergquist. Increased Risk of Colorectal Cancer and Dysplasia in Patients With Crohn's Colitis and Primary Sclerosing Cholangitis. Diseases of the Colon & Rectum 2011; 54(11): 1392 doi: 10.1097/DCR.0b013e31822bbcc1
18
Kristin Kaasen Jørgensen, Lina Lindström, Milada Cvancarova, Maria Castedal, Styrbjörn Friman, Erik Schrumpf, Aksel Foss, Helena Isoniemi, Arno Nordin, Kathrine Holte, Allan Rasmussen, Annika Bergquist, Morten H Vatn, Kirsten Muri Boberg. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study. Scandinavian Journal of Gastroenterology 2012; 47(8-9): 1021 doi: 10.3109/00365521.2012.685754
19
Johanna Haapamäki, Andrea Tenca, Harri Sintonen, Nina Barner‐Rasmussen, Martti A. Färkkilä. Health‐related quality of life among patients with primary sclerosing cholangitis. Liver International 2015; 35(9): 2194 doi: 10.1111/liv.12775
20
Nahla Azzam, Yazed AlRuthia, Othman Alharbi, Abdulrahman Aljebreen, Majid Almadi, Edward V. Loftus. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease. Hepatology International 2020; 14(6): 1114 doi: 10.1007/s12072-020-10110-5
21
João Sabino, Joren tenHove, Joana Torres. Biomarkers in Inflammatory Bowel Diseases. 2019; : 191 doi: 10.1007/978-3-030-11446-6_16
22
Lola-Jade Palmieri, Dominique Rainteau, Harry Sokol, Laurent Beaugerie, Marie Dior, Benoit Coffin, Lydie Humbert, Thibaut Eguether, André Bado, Sandra Hoys, Claire Janoir, Henri Duboc. Inhibitory Effect of Ursodeoxycholic Acid on Clostridium difficile Germination Is Insufficient to Prevent Colitis: A Study in Hamsters and Humans. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.02849
23
Neelam G Gidwaney, Swati Pawa, Kiron M Das. Pathogenesis and clinical spectrum of primary sclerosing cholangitis. World Journal of Gastroenterology 2017; 23(14): 2459-2469 doi: 10.3748/wjg.v23.i14.2459
24
·玉山江 唐努尔. The Latest Progress in Evaluating the Severity and Prognosis of Inflammatory Bowel Disease. Advances in Clinical Medicine 2023; 13(12): 19973 doi: 10.12677/ACM.2023.13122813
25
Gianluca Pellino, Rosa Marcellinaro, Guido Sciaudone, Alfonso Reginelli, Pasquale Esposito, Gabriele Riegler, Silvestro Canonico, Vincenzo Villanacci, Francesco Selvaggi. Large bowel cancer in the setting of inflammatory bowel disease. European Surgery 2016; 48(4): 191 doi: 10.1007/s10353-016-0434-0
26
L. Lindström, K. M. Boberg, O. Wikman, I. Friis‐Liby, R. Hultcrantz, H. Prytz, H. Sandberg‐Gertzén, P. Sangfelt, A. Rydning, G. Folvik, M. Gangsøy‐Kristiansen, Å. Danielsson, Annika Bergquist. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia. Alimentary Pharmacology & Therapeutics 2012; 35(4): 451 doi: 10.1111/j.1365-2036.2011.04966.x
27
Carolina Palmela, Farhad Peerani, Daniel Castaneda, Joana Torres, Steven H. Itzkowitz. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features. Gut and Liver 2018; 12(1): 17 doi: 10.5009/gnl16510
28
Kristin Kaasen Jrgensen, Krzysztof Grzyb, Knut E.A. Lundin, Ole Petter F. Clausen, Geir Aamodt, Erik Schrumpf, Morten H. Vatn, Kirsten Muri Boberg. Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients. Inflammatory Bowel Diseases 2012; 18(3): 536 doi: 10.1002/ibd.21699
29
Udayakumar Navaneethan, Gursimran Kochhar, Preethi G.K. Venkatesh, Brian Lewis, Bret A. Lashner, Feza H. Remzi, Bo Shen, Ravi P. Kiran. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis. Gastrointestinal Endoscopy 2012; 75(5): 1045 doi: 10.1016/j.gie.2012.01.015
30
Amanda Ricciuto, Binita M. Kamath, Anne M. Griffiths. The IBD and PSC Phenotypes of PSC-IBD. Current Gastroenterology Reports 2018; 20(4) doi: 10.1007/s11894-018-0620-2
31
Sanjay K. Murthy, Joseph D. Feuerstein, Geoffrey C. Nguyen, Fernando S. Velayos. AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review. Gastroenterology 2021; 161(3): 1043 doi: 10.1053/j.gastro.2021.05.063
32
Tina Boortalary, David Loren. Hepato-Pancreato-Biliary Malignancies. 2021; : 1 doi: 10.1007/978-3-030-37482-2_15-1
33
Sanjay K. Murthy, Geoffrey C. Nguyen. Cancer Screening in Inflammatory Bowel Disease. 2019; : 1 doi: 10.1007/978-3-030-15301-4_1
34
Iria Bastón-Rey, Iago Rodríguez-Lago, Ana María Luque, Berta Caballol, Carlos Soutullo-Castiñeiras, Ana Bravo, Andrés Castaño, Beatriz Gros, Lorena Bernal, María Teresa Diz-Lois, Horacio Alonso-Galán, Fiorella Cañete, Beatriz Castro, Pablo Pérez-Galindo, Carlos González-Muñoza, Ismael El Hajra, Pilar Martínez-Montiel, Inmaculada Alonso-Abreu, Francisco Mesonero, María González-Vivo, Laia Peries, Eduardo Martín-Arranz, Carlos Abril, Ignacio Marín-Jiménez, Ruth Baltar, Miren Vicuña, Nadia Moreno, Eduard Brunet, Cristina Rubín de Célix, Ingrid Fajardo, Noelia Cruz, Cristina Calvino-Suárez, María Rojas-Feria, Agnes Fernández-Clotet, Marta Gimeno-Torres, Laura Nieto-Garcia, Daniel de la Iglesia, Yamile Zabana, Cristina Suárez-Ferrer, Manuel Barreiro de Acosta. The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU. Inflammatory Bowel Diseases 2024;  doi: 10.1093/ibd/izae041
35
Fabian Schnitzler, Matthias Friedrich, Johannes Stallhofer, Ulf Schönermarck, Michael Fischereder, Antje Habicht, Nazanin Karbalai, Christiane Wolf, Marianne Angelberger, Torsten Olszak, Florian Beigel, Cornelia Tillack, Burkhard Göke, Reinhart Zachoval, Gerald Denk, Markus Guba, Christian Rust, Norbert Grüner, Stephan Brand, Markus M. Heimesaat. Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort. PLOS ONE 2015; 10(8): e0135807 doi: 10.1371/journal.pone.0135807
36
Bruno César da Silva, Andre Castro Lyra, Raquel Rocha, Genoile Oliveira Santana. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World Journal of Gastroenterology 2014; 20(28): 9458-9467 doi: 10.3748/wjg.v20.i28.9458
37
Elisa Marabotto, Stefano Kayali, Silvia Buccilli, Francesca Levo, Giorgia Bodini, Edoardo G. Giannini, Vincenzo Savarino, Edoardo Vincenzo Savarino. Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A Review. Cancers 2022; 14(17): 4254 doi: 10.3390/cancers14174254
38
Deepak Joshi, Ingvar Bjarnason, Ajay Belgaumkar, John O'Grady, Abid Suddle, Michael A. Heneghan, Varuna Aluvihare, Mohammed Rela, Nigel Heaton, Kosh Agarwal. The impact of inflammatory bowel disease post‐liver transplantation for primary sclerosing cholangitis. Liver International 2013; 33(1): 53 doi: 10.1111/j.1478-3231.2011.02677.x
39
Alyssa Parian, Mark Lazarev. Who and how to screen for cancer in at-risk inflammatory bowel disease patients. Expert Review of Gastroenterology & Hepatology 2015; 9(6): 731 doi: 10.1586/17474124.2015.1003208
40
Erin W. Thackeray, Phunchai Charatcharoenwitthaya, Diaa Elfaki, Emmanouil Sinakos, Keith D. Lindor. Colon Neoplasms Develop Early in the Course of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology 2011; 9(1): 52 doi: 10.1016/j.cgh.2010.09.020
41
Pavel Wohl, Alzbeta Krausova, Petr Wohl, Ondrej Fabian, Lukas Bajer, Jan Brezina, Pavel Drastich, Mojmir Hlavaty, Petra Novotna, Michal Kahle, Julius Spicak, Martin Gregor. Limited validity of Mayo endoscopic subscore in ulcerative colitis with concomitant primary sclerosing cholangitis. World Journal of Gastrointestinal Endoscopy 2024; 16(11): 607-616 doi: 10.4253/wjge.v16.i11.607
42
Kymberly D.S. Watt, Rachel A. Pedersen, Walter K. Kremers, Julie K. Heimbach, William Sanchez, Gregory J. Gores. Long-term Probability of and Mortality From De Novo Malignancy After Liver Transplantation. Gastroenterology 2009; 137(6): 2010 doi: 10.1053/j.gastro.2009.08.070
43
Ganglei Liu, Jingmei Lin, Hao Xie, Bo Shen, Luca Stocchi, Xiuli Liu. Histomorphological features and prognosis of colitis-associated colorectal cancer in patients with primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology 2015; 50(11): 1389 doi: 10.3109/00365521.2015.1052094
44
Amanda Ricciuto, Bettina E. Hansen, Brian Ngo, Marina Aloi, Thomas D. Walters, Peter C. Church, Abigail Mazurek, Maryam Khan, Nicholas Carman, Iram Siddiqui, Geoffrey C. Nguyen, Binita M. Kamath, Anne M. Griffiths. Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth Impairment. Clinical Gastroenterology and Hepatology 2020; 18(7): 1509 doi: 10.1016/j.cgh.2019.08.048
45
Kirsten Boonstra, Karel J. van Erpecum, Karin M.J. van Nieuwkerk, Joost P.H. Drenth, Alexander C. Poen, Ben J.M. Witteman, Hans A.R.E. Tuynman, Ulrich Beuers, Cyriel Y. Ponsioen. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflammatory Bowel Diseases 2012; 18(12): 2270 doi: 10.1002/ibd.22938
46
Kim N. van Munster, Annika Bergquist, Cyriel Y. Ponsioen. Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?. Journal of Hepatology 2024; 80(1): 155 doi: 10.1016/j.jhep.2023.09.031
47
Magali Svrcek, Paula Borralho Nunes, Vincenzo Villanacci, Laurent Beaugerie, Gerhard Rogler, Gert De Hertogh, Monika Tripathi, Roger Feakins. Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease–Related Colorectal Neoplastic Lesions: The Role of Inflammation. Journal of Crohn's and Colitis 2018;  doi: 10.1093/ecco-jcc/jjy132
48
Santosh Kumar Behera, Ardhendu Bhusan Praharaj, Gayathri Chalikonda, Gowru Srivani, Namita Mahapatra. Theranostics Approaches to Gastric and Colon Cancer. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 167 doi: 10.1007/978-981-15-2017-4_11
49
Mohamed Attauabi, Mirabella Zhao, Flemming Bendtsen, Johan Burisch. Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2021; 27(6): 927 doi: 10.1093/ibd/izaa167
50
Piotr Milkiewicz, Ewa Wunsch. Inflammation and Gastrointestinal Cancers. Recent Results in Cancer Research 2011; 185: 117 doi: 10.1007/978-3-642-03503-6_7
51
Friederike Cordes, Thomas Laumeyer, Joachim Gerß, Markus Brückner, Frank Lenze, Tobias Nowacki, Emile Rijcken, Phil Tepasse, Hartmut Schmidt, Torsten Kucharzik, Dominik Bettenworth. Distinct Disease Phenotype of Ulcerative Colitis in Patients With Coincident Primary Sclerosing Cholangitis: Evidence From a Large Retrospective Study With Matched Cohorts. Diseases of the Colon & Rectum 2019; 62(12): 1494 doi: 10.1097/DCR.0000000000001496
52
O. Chazouillères. Post’U FMC-HGE. 2009; : 1 doi: 10.1007/978-2-287-99247-6_1
53
E. Gizard, A. C. Ford, J.-P. Bronowicki, L. Peyrin-Biroulet. Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2014; 40(1): 3 doi: 10.1111/apt.12794
54
Gerhard Rogler, Stephan Vavricka. Exposome in IBD. Inflammatory Bowel Diseases 2015; 21(2): 400 doi: 10.1097/MIB.0000000000000229
55
Han-Han Zheng, Xue-Liang Jiang. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2016; 28(4): 383 doi: 10.1097/MEG.0000000000000576
56
Florian Rennebaum, Claudia Demmig, Hartmut H. Schmidt, Richard Vollenberg, Phil-Robin Tepasse, Jonel Trebicka, Wenyi Gu, Hansjoerg Ullerich, Iyad Kabar, Friederike Cordes. Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study. International Journal of Molecular Sciences 2023; 24(20): 15431 doi: 10.3390/ijms242015431
57
M. H. Imam, E. W. Thackeray, K. D. Lindor. Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis. Colorectal Disease 2013; 15(2): 198 doi: 10.1111/j.1463-1318.2012.03133.x
58
Shintaro Akiyama, Soma Fukuda, Joshua M Steinberg, Hideo Suzuki, Kiichiro Tsuchiya. Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases. World Journal of Gastroenterology 2022; 28(25): 2843-2853 doi: 10.3748/wjg.v28.i25.2843
59
Harry Sokol, Olivier Chazouilleres. Colorectal neoplasia in PSC–IBD patients: are times changing?. Liver International 2012; 32(2): 175 doi: 10.1111/j.1478-3231.2011.02671.x
60
J. Torres, X. Bao, A. Goel, J.‐F. Colombel, J. Pekow, B. Jabri, K.M. Williams, A. Castillo, J.A. Odin, K. Meckel, F. Fasihuddin, I. Peter, S. Itzkowitz, J. Hu. The features of mucosa‐associated microbiota in primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics 2016; 43(7): 790 doi: 10.1111/apt.13552
61
Matteo Bramuzzo, Stefano Martelossi, Giuliano Torre, Sabrina Cardile, Serena Arrigo, Silvia Vignola, Federica Ferrari, Giovanna Zuin, Maria Teresa Illiceto, Marco Gasparetto, Salvatore Pellegrino, Claudio Romano, Giuseppe Maggiore, Marcella Montico, Marina Aloi. Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(2): 259 doi: 10.1097/MPG.0000000000001078
62
Siddharth Singh, Jayant A. Talwalkar. Primary Sclerosing Cholangitis: Diagnosis, Prognosis, and Management. Clinical Gastroenterology and Hepatology 2013; 11(8): 898 doi: 10.1016/j.cgh.2013.02.016
63
Anthony OʼConnor, Christopher D. Packey, Mona Akbari, Alan C. Moss. Mesalamine, but Not Sulfasalazine, Reduces the Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2015; 21(11): 2562 doi: 10.1097/MIB.0000000000000540
64
Joanna Raszeja-Wyszomirska, Robert Kucharski, Marta Zygmunt, Krzysztof Safranow, Tomasz Miazgowski. The Impact of Fragility Fractures on Health-Related Quality of Life in Patients With Primary Sclerosing Cholangitis. Hepatitis Monthly 2015; 15(4) doi: 10.5812/hepatmon.25539
65
Jacques Cosnes, Harry Sokol. Crohn's Disease and Ulcerative Colitis. 2017; : 653 doi: 10.1007/978-3-319-33703-6_61
66
Trevor J Laborda, M Kyle Jensen, Marianne Kavan, Mark Deneau. Treatment of primary sclerosing cholangitis in children. World Journal of Hepatology 2019; 11(1): 19-36 doi: 10.4254/wjh.v11.i1.19
67
Jacques Cosnes, Harry Sokol, Philippe Seksik. Crohn's Disease and Ulcerative Colitis. 2012; : 713 doi: 10.1007/978-1-4614-0998-4_56
68
Sophie Restellini, Olivier Chazouillères, Jean‐Louis Frossard. Hepatic manifestations of inflammatory bowel diseases. Liver International 2017; 37(4): 475 doi: 10.1111/liv.13265
69
Siddharth Singh, Edward V Loftus, Jayant A Talwalkar. Inflammatory Bowel Disease after Liver Transplantation for Primary Sclerosing Cholangitis. American Journal of Gastroenterology 2013; 108(9): 1417 doi: 10.1038/ajg.2013.163
70
Eva Vlčková, Katarína Mitrová. Sclerosing cholangitis in children with inflammatory bowel disease. Česko-slovenská pediatrie 2023; 78(3): 182 doi: 10.55095/CSPediatrie2023/025
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345